GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » Debt-to-EBITDA

P&K Skin Research Center Co (XKRX:347740) Debt-to-EBITDA : 0.06 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

P&K Skin Research Center Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩354 Mil. P&K Skin Research Center Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩314 Mil. P&K Skin Research Center Co's annualized EBITDA for the quarter that ended in Dec. 2023 was ₩11,204 Mil. P&K Skin Research Center Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for P&K Skin Research Center Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:347740' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.08   Med: 0.1   Max: 0.13
Current: 0.09

During the past 7 years, the highest Debt-to-EBITDA Ratio of P&K Skin Research Center Co was 0.13. The lowest was 0.08. And the median was 0.10.

XKRX:347740's Debt-to-EBITDA is ranked better than
94.29% of 105 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.96 vs XKRX:347740: 0.09

P&K Skin Research Center Co Debt-to-EBITDA Historical Data

The historical data trend for P&K Skin Research Center Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

P&K Skin Research Center Co Debt-to-EBITDA Chart

P&K Skin Research Center Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial 0.13 0.10 0.11 0.08 0.09

P&K Skin Research Center Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.05 0.10 0.25 0.13 0.06

Competitive Comparison of P&K Skin Research Center Co's Debt-to-EBITDA

For the Diagnostics & Research subindustry, P&K Skin Research Center Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


P&K Skin Research Center Co's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, P&K Skin Research Center Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where P&K Skin Research Center Co's Debt-to-EBITDA falls into.



P&K Skin Research Center Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

P&K Skin Research Center Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(354.273 + 313.962) / 7124.446
=0.09

P&K Skin Research Center Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(354.273 + 313.962) / 11204.024
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


P&K Skin Research Center Co  (XKRX:347740) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


P&K Skin Research Center Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


P&K Skin Research Center Co (XKRX:347740) Business Description

Traded in Other Exchanges
N/A
Address
National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236
P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines